Hong Kong biomedical stocks rebounded sharply, Rongchang Bio (09995.HK) rose more than 9.5%, WuXi Bio (02269.HK) rose more than 7.5%, WuXi PharmaTech (02268.HK) rose more than 6%, WuXi PharmaTech (02359.HK), Junshi Biosciences (01877.HK) rose more than 5%, Konoya (02162.HK), Fuhong Hanlin (02696.HK) and so on.
Hong Kong biomedical stocks fell again in the afternoon, Junshi Biosciences (01877.HK), Kailaiying (06821.HK) fell more than 7%, Nuocheng Jianhua (09969.HK) fell more than 4.5%, drug combination (02268.HK), Tiger medicine (03347.HK), Kangfang biological (09926.HK) fell more than 3%.
Hong Kong stocks biomedical concept continued to decline in the afternoon, Tiger medicine (03347.HK) fell more than 6%, Junshi Biosciences (01877.HK), WuXi PharmaTech (02359.HK), Zaiding medicine (09688.HK), BeiGene (06160.HK) and other stocks fell.
Hong Kong stocks closed, the Hang Seng Index closed up 0.68%, the Branch Index closed up 0.73%, the biotechnology sector rose sharply, Junshi Biosciences (01877.HK) rose 33.75%, Ge Li Pharmaceutical (01672.HK) rose 15.4%.
Hong Kong biomedical plate early strong, Zaiding medicine (09688.HK) rose more than 12%, Junshi Biosciences (01877.HK) rose more than 5%, BeiGene (06160.HK), WuXi PharmaTech (02359.HK) and so on up.
港股生物医药板块盘初走强,再鼎医药(09688.HK)涨超12%,君实生物(01877.HK)涨超5%,百济神州(06160.HK)、药明康德(02359.HK)等跟涨。